Philip Auyang, MD
Vascular Surgery · Houston, TXNPI 1114306545
Payments from drug & device makers
Across 415 payments — averaging $102.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Penumbra, Inc.$5K
- Cagent Vascular Inc$5K
- Endologix LLC$4K
- Inari Medical, Inc.$4K
- Silk Road Medical, Inc.$3K
- plus $15K from 36 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 82 | $6,817 |
| Penumbra, Inc. | 33 | $5,084 |
| Cagent Vascular Inc | 26 | $4,563 |
| Endologix LLC | 32 | $4,334 |
| Inari Medical, Inc. | 25 | $4,022 |
| Silk Road Medical, Inc. | 26 | $3,041 |
| Boston Scientific | 37 | $2,411 |
| Bolton Medical Inc | 16 | $1,966 |
| Aroa Biosurgery Incorporated | 8 | $1,624 |
| W. L. Gore & Associates, Inc. | 22 | $1,495 |
| Angiodynamics, Inc. | 9 | $1,110 |
| Biom'up France SAS | 5 | $640 |
| BD | 6 | $579 |
| Imperative Care, Inc | 5 | $540 |
| Baxter Healthcare | 7 | $534 |
| Johnson & Johnson(2 entities) | 9 | $515 |
| Cook Medical LLC | 11 | $494 |
| Shockwave Medical, Inc | 11 | $457 |
| Abbott | 4 | $303 |
| Davol Inc. | 2 | $248 |
| Surmodics, Inc. | 7 | $216 |
| Mozarc Medical US LLC | 3 | $203 |
| Teleflex LLC | 2 | $186 |
| Stryker | 1 | $166 |
| Organogenesis Inc. | 1 | $154 |
| Bone Support Inc. | 1 | $153 |
| Dilon Technologies, Inc. | 2 | $152 |
| Bard Peripheral Vascular, Inc. | 2 | $105 |
| Mindray DS USA, Inc. | 2 | $94 |
| Atricure, Inc. | 2 | $71 |
| Lemaitre Vascular, Inc. | 2 | $49 |
| KCI USA, Inc. | 1 | $47 |
| Irhythm Technologies, Inc. | 2 | $45 |
| Pfizer | 2 | $44 |
| Solventum Corporation | 2 | $34 |
| Octapharma USA, Inc. | 1 | $31 |
| Livanova USA, Inc. | 1 | $29 |
| Avinger Inc. | 1 | $24 |
| Hydrofera LLC | 1 | $23 |
| Altathera Pharmaceuticals LLC | 1 | $22 |
| Cvrx, Inc. | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
How this compares
$42,663 in reported general payments places this provider in the 80th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular surgery in Houston
- Alan LumsdenHouston$2.4M
- Gustavo OderichHouston$999K
- Samuel LeonardHouston$431K
- Ali AzizzadehHouston$387K
- Jean BismuthHouston$382K
- Kristofer Charlton-OuwHouston$240K
- Maham RahimiHouston$221K
- Jayer ChungHouston$179K
- Steven MaximusHouston$140K
- Charudatta BavareHouston$130K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.